WHO Experts “AstraZeneca Vaccine, Even Over 65 Years Old”

Vaccine experts from the World Health Organization (WHO) recommended that a novel coronavirus infection (Corona 19) vaccine developed by the multinational pharmaceutical company AstraZeneca and the University of Oxford in the UK can be used for the elderly over 65 years of age.

According to AFP, WHO’s Expert Strategic Advisory Group (SAGE) said on the 10th (local time) that “considering the totality of available evidence, WHO recommends that people 65 years of age or older use the vaccine.”

In addition, SAGE added that the AstraZeneca vaccine “can be used where the mutation is present,” despite recent research findings that it is less effective against mutant viruses from South Africa.

Earlier, controversy about the effectiveness and safety of the AstraZeneca vaccine was raised due to lack of data on the elderly over the age of 65. Some countries, such as France, Germany, and Sweden, have also limited the age of AstraZeneca vaccine to under 65 years of age. The Korea Food and Drug Administration approved the use of the AstraZeneca vaccine in Korea on the 10th. It was decided to state that the use of the above-described elderly people should be carefully determined.’ In the meantime, it is noteworthy whether the WHO’s recommendation could alleviate controversy about the efficacy of the AstraZeneca vaccine.


(Seoul = News 1)